LCM
VNDA icon

Landscape Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Landscape Capital Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-44,190
Closed -$672K – 683
2017
Q4 		$672K Buy
+44,190
New +$656K 0.06% 317
2016
Q1 		– Sell
-25,531
Closed -$238K – 831
2015
Q4 		$238K Sell
25,531
-15,878
-38% -$158K 0.03% 772
2015
Q3 		$467K Buy
+41,409
New +$507K 0.06% 349

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Landscape Capital Management's VNDA Position: Q1 2018 in Review

Landscape Capital Management sold out of Vanda Pharmaceuticals (VNDA) in Q1 2018, closing a stake of 44,190 shares — an estimated $672K sold.

Landscape Capital Management first reported a position in VNDA in Q3 2015 and held it in 3 quarters. The position peaked at $672K in Q4 2017. 131 funds tracked by Wall St. Rank hold VNDA as of Q1 2018.

  • Landscape Capital Management reported no remaining Vanda Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Landscape Capital Management sold 44,190 Vanda Pharmaceuticals shares in Q1 2018, an estimated $672K.
  • Landscape Capital Management first reported a position in Vanda Pharmaceuticals in Q3 2015 and held it in 3 quarters.
  • Landscape Capital Management's Vanda Pharmaceuticals position peaked at $672K in Q4 2017.
  • 131 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2018.

Based on Landscape Capital Management's 13F filing for Q1 2018, filed 11 May 2018.